Northern Trust Corp Protalix Bio Therapeutics, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 731,742 shares of PLX stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
731,742
Previous 52,291
1299.37%
Holding current value
$1.69 Million
Previous $53,000
2549.06%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PLX
# of Institutions
50Shares Held
4.58MCall Options Held
40.9KPut Options Held
5.3K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.12MShares$2.58 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$896,0970.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$769,6250.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$706,2800.04% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$623,7000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $115M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...